Jump to search

November 2017arrow

UC study finds performance on med school interviews linked to demographics

November 21, 2017

The medical school interview – a key determinant in the admissions process and, ultimately, in the physician workforce – appears to skew for or against applicants depending on their age, gender and self-identified disadvantaged socioeconomic status.

Maternal immune response affects genes in microglia, neural development

November 20, 2017

UC Davis MIND Institute esearchers have shown in a mouse model that an elevated maternal immune response changes the epigenetic landscape in offspring’s microglia, immune cells found in the brain and spinal cord. These changes affect genes associated with immune signaling and neural development, some of which have been implicated in autism spectrum disorder (ASD). The study was published online in the journal Glia.

In cancer, talking about bad news can be good

November 17, 2017

Giving bad news is never easy, especially when it’s life or death. But when an oncologist delivers a poor prognosis to a cancer patient, does it harm their relationship?  Some research studies have suggested it can.

Unlocking the genetics of cancer

November 7, 2017

For many, breast cancer is more than just a disease – it’s personal. One in eight women will be diagnosed with breast cancer at some point in their lives. But through new discoveries at the genetic level, the personal nature of cancer will eventually be what helps to beat it.

October 2017arrow

Peers can reduce tobacco use among younger smokers

October 25, 2017

Participating in a brief intervention delivered by their peers in community settings can help reduce smoking among youth and young adults, a new study from a team of tobacco-cessation researchers shows.

MIND Institute researchers detect reversal of behavioral deficits in a rare genetic disorder

October 23, 2017

Research conducted in mice at the UC Davis MIND Institute suggests that a drug treatment can reverse cognitive deficits and social abnormalities in a rare genetic disorder, 16p11.2 deletion syndrome, which includes symptoms of intellectual disability and autism spectrum disorder, among others. Results of parallel studies conducted at the MIND and at the Massachusetts Institute of Technology Picower Institute for Learning and Memory appear in the latest issue of the journal Neuropsychopharmacology.

Moonshot grant advances immune therapy for dogs - and one day people - with cancer

October 20, 2017

UC Davis has received its first National Cancer Institute (NCI) Moonshot grant  ̶  $2.5 million over five years  ̶  to explore immunotherapy treatments for dogs who develop melanoma and osteosarcoma and that may one day benefit humans, as well.

Cancer Center hosts lung cancer research conference

October 19, 2017

Members of the UC Davis Comprehensive Cancer Center lung cancer treatment team will present at WCLC 2017, a one-day conference on Saturday, Nov. 11, from 7 a.m. to 4 p.m. in San Francisco. Presenters will share the latest lung cancer and other thoracic malignancy advances highlighted at the recent 18th Annual World Conference on Lung Cancer in Japan.

Noncompliance thwarts comprehensive background check policy for private-party sales, study finds

October 9, 2017

Of the three states that recently expanded comprehensive background check (CBC) policies to include all gun transfers, including those among private parties, only Delaware showed an overall increase in firearm background checks. Washington and Colorado had no changes, which the study authors say suggests that compliance and enforcement were incomplete.

"Smart" immune cells: Emerging cancer therapy research at UC Davis receives a boost with NIH award

October 6, 2017

Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics, has received a $1.5 million award from the National Institutes of Health to advance the development of “smart” immune cells for therapies to treat cancer and other diseases. The five-year NIH Director’s New Innovator Award aims to provide new insight into how to engineer immune cells to control their recruitment and response to tumors.

September 2017arrow

UC Davis receives $8 million to expand access to stem cell clinical trials

September 28, 2017

The California Institute for Regenerative Medicine today awarded a nearly $8 million grant to University of California, Davis, stem cell researchers to launch a special clinical trials program in Sacramento to accelerate the therapeutic development and delivery of stem cell therapies in human patients.

$3.3 million grant funds early detection of pancreatic cancer

September 27, 2017

UC Davis researchers, led by Julie Sutcliffe, have received a $3.3 million grant from the National Institutes of Health to advance efforts to diagnose pancreatic cancer before it spreads.

Too little is known about the compounds in wildfire smoke

September 25, 2017

How do fire-suppression chemicals and pesticides affect wildfire smoke and the health of those who breathe it? UC Davis graduate students discovered that this question cannot be answered based on current scientific evidence and, in a review published in Current Topics in Toxicology, they recommend more studies on the compounds in wildfire smoke.

UC Davis MIND Institute wins coveted ACE grant

September 7, 2017

The UC Davis MIND Institute has been awarded a 5-year, $12 million Autism Centers of Excellence (ACE) grant, one of five in the nation, to create a “Center for the Development of Phenotype-based Treatments of Autism Spectrum Disorder.”